Kyverna Therapeutics, Inc.(KYTX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Kyverna Therapeutics, Inc. (KYTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. KYTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of KYTX by reported 13-F value include GordonMD Global Investments, GILEAD SCIENCES, BlackRock, based on the most recent SEC filings. KYTX trades on the Nasdaq exchange and files with the SEC under CIK 1994702. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KYTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Kyverna Therapeutics, Inc. directly from SEC EDGAR.